HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philipp le Coutre Selected Research

Colorectal Neoplasms (Colorectal Cancer)

8/2022Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls.
1/2007Cetuximab: appraisal of a novel drug against colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philipp le Coutre Research Topics

Disease

59BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2024 - 01/2002
23Philadelphia Chromosome
01/2023 - 10/2002
10Neoplasms (Cancer)
01/2023 - 01/2007
8Leukemia
01/2020 - 10/2002
7Blast Crisis (Blast Phase)
11/2023 - 03/2005
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 04/2010
5Thrombocytopenia (Thrombopenia)
05/2024 - 01/2012
5Disease Progression
02/2024 - 04/2014
4Primary Myelofibrosis (Myelosclerosis)
01/2020 - 01/2016
3Neutropenia
01/2023 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 01/2007
2Pancreatitis
12/2019 - 01/2016
2Exanthema (Rash)
01/2016 - 10/2002
2Anemia
01/2016 - 01/2012
2Chromosome Aberrations (Chromosome Abnormalities)
02/2014 - 04/2010
1COVID-19
05/2024
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024
1Hematologic Diseases (Blood Diseases)
02/2024
1VEXAS syndrome
02/2024
1Musculoskeletal Pain
01/2023
1Fatigue
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2023
1Multiple Myeloma
01/2021
1Infections
01/2020
1Splenomegaly
01/2020
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2019
1Diarrhea
01/2018
1Hairy Cell Leukemia
01/2018
1Prostatic Neoplasms (Prostate Cancer)
08/2017
1Atherosclerosis
08/2017
1Lymphocytosis
05/2016
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2016
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016
1Thrombocytosis (Thrombocythemia)
01/2016
1Atrial Fibrillation
01/2016
1Pulmonary Hypertension
02/2015
1Peripheral Arterial Occlusive Disease 1
02/2015
1Residual Neoplasm
10/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2014
1Pain (Aches)
07/2014
1Pathologic Complete Response
02/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2012
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
11/2010
1Hyperthyroidism
11/2010
1Hypothyroidism
11/2010
1Headache (Headaches)
06/2010
1Genetic Translocation (Chromosomal Translocation)
01/2010
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2007
1Necrosis
01/2006

Drug/Important Bio-Agent (IBA)

34Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2002
27Tyrosine Kinase InhibitorsIBA
05/2024 - 03/2005
23nilotinibFDA Link
01/2022 - 11/2007
8Phosphotransferases (Kinase)IBA
12/2019 - 10/2002
7Dasatinib (BMS 354825)FDA Link
01/2019 - 11/2010
6bosutinibIBA
01/2023 - 01/2018
5ponatinibIBA
10/2023 - 02/2015
4asciminibIBA
05/2024 - 12/2019
4bcr-abl Fusion ProteinsIBA
02/2008 - 01/2002
3Lipase (Acid Lipase)FDA Link
05/2024 - 01/2016
3ruxolitinibIBA
01/2020 - 01/2016
3Tyrosine (L-Tyrosine)FDA Link
01/2015 - 03/2005
2EnzymesIBA
02/2024 - 01/2023
2Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2010
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2010 - 01/2002
2Messenger RNA (mRNA)IBA
03/2005 - 01/2004
1Janus Kinase InhibitorsIBA
01/2020
1Janus KinasesIBA
01/2020
1Adenosine Triphosphate (ATP)IBA
12/2019
1NVP-BKM120IBA
12/2019
1AntigensIBA
10/2019
1EpitopesIBA
10/2019
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
10/2019
1Immunotoxins (Immunotoxin)IBA
01/2018
1immunotoxin HA22IBA
01/2018
1Prednisone (Sone)FDA LinkGeneric
08/2017
1Docetaxel (Taxotere)FDA Link
08/2017
1anagrelide (Agrylin)FDA LinkGeneric
01/2016
1Analgesics (Analgesic Drugs)IBA
07/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2014
1Proton Pump InhibitorsIBA
08/2012
1HomoharringtonineIBA
10/2011
1Oncogene Proteins (Oncogene Protein)IBA
10/2008
1Irinotecan (Camptosar)FDA LinkGeneric
01/2007
1Cetuximab (Erbitux)FDA Link
01/2007
1CytokinesIBA
01/2006
1Peptides (Polypeptides)IBA
01/2006
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
03/2005

Therapy/Procedure

21Therapeutics
02/2024 - 01/2002
6Stem Cell Transplantation
01/2016 - 04/2010
3Hematopoietic Stem Cell Transplantation
01/2021 - 10/2014
3Transplantation
01/2014 - 04/2011
2Aftercare (After-Treatment)
11/2023 - 05/2016
2Drug Therapy (Chemotherapy)
01/2021 - 04/2003
2Radiotherapy
01/2007 - 03/2005
1Exercise Therapy (Therapy, Exercise)
01/2023
1Immunotherapy
10/2019
1Heart Transplantation (Grafting, Heart)
01/2014
1Organ Transplantation
01/2014
1Drug Tapering
01/2012